Postbooster Antibodies from Humans as Source of Diphtheria Antitoxin

Diphtheria antitoxin for therapeutic use is in limited supply. A potential source might be affinity-purified antibodies originally derived from plasma of adults who received a booster dose of a vaccine containing diphtheria toxoid. These antibodies might be useful for treating even severe cases of d...

Descripción completa

Detalles Bibliográficos
Autores principales: Bermejo-Martin, Jesús F., Avila-Alonso, Ana, González-Rivera, Milagros, Tamayo, Eduardo, Eiros, Jose María, Almansa, Raquel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2016
Materias:
Dispatch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918160/
https://www.ncbi.nlm.nih.gov/pubmed/27314309
http://dx.doi.org/10.3201/eid2207.151670
_version_ 1782439069883564032
author Bermejo-Martin, Jesús F.
Avila-Alonso, Ana
González-Rivera, Milagros
Tamayo, Eduardo
Eiros, Jose María
Almansa, Raquel
author_facet Bermejo-Martin, Jesús F.
Avila-Alonso, Ana
González-Rivera, Milagros
Tamayo, Eduardo
Eiros, Jose María
Almansa, Raquel
author_sort Bermejo-Martin, Jesús F.
collection PubMed
description Diphtheria antitoxin for therapeutic use is in limited supply. A potential source might be affinity-purified antibodies originally derived from plasma of adults who received a booster dose of a vaccine containing diphtheria toxoid. These antibodies might be useful for treating even severe cases of diphtheria.
format Online
Article
Text
id pubmed-4918160
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-49181602016-07-01 Postbooster Antibodies from Humans as Source of Diphtheria Antitoxin Bermejo-Martin, Jesús F. Avila-Alonso, Ana González-Rivera, Milagros Tamayo, Eduardo Eiros, Jose María Almansa, Raquel Emerg Infect Dis Dispatch Diphtheria antitoxin for therapeutic use is in limited supply. A potential source might be affinity-purified antibodies originally derived from plasma of adults who received a booster dose of a vaccine containing diphtheria toxoid. These antibodies might be useful for treating even severe cases of diphtheria. Centers for Disease Control and Prevention 2016-07 /pmc/articles/PMC4918160/ /pubmed/27314309 http://dx.doi.org/10.3201/eid2207.151670 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Dispatch
Bermejo-Martin, Jesús F.
Avila-Alonso, Ana
González-Rivera, Milagros
Tamayo, Eduardo
Eiros, Jose María
Almansa, Raquel
Postbooster Antibodies from Humans as Source of Diphtheria Antitoxin
title Postbooster Antibodies from Humans as Source of Diphtheria Antitoxin
title_full Postbooster Antibodies from Humans as Source of Diphtheria Antitoxin
title_fullStr Postbooster Antibodies from Humans as Source of Diphtheria Antitoxin
title_full_unstemmed Postbooster Antibodies from Humans as Source of Diphtheria Antitoxin
title_short Postbooster Antibodies from Humans as Source of Diphtheria Antitoxin
title_sort postbooster antibodies from humans as source of diphtheria antitoxin
topic Dispatch
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918160/
https://www.ncbi.nlm.nih.gov/pubmed/27314309
http://dx.doi.org/10.3201/eid2207.151670
work_keys_str_mv AT bermejomartinjesusf postboosterantibodiesfromhumansassourceofdiphtheriaantitoxin
AT avilaalonsoana postboosterantibodiesfromhumansassourceofdiphtheriaantitoxin
AT gonzalezriveramilagros postboosterantibodiesfromhumansassourceofdiphtheriaantitoxin
AT tamayoeduardo postboosterantibodiesfromhumansassourceofdiphtheriaantitoxin
AT eirosjosemaria postboosterantibodiesfromhumansassourceofdiphtheriaantitoxin
AT almansaraquel postboosterantibodiesfromhumansassourceofdiphtheriaantitoxin

Ejemplares similares